3-iodobenzylguanidine has been researched along with Sensitivity and Specificity in 225 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.44) | 18.7374 |
| 1990's | 45 (20.00) | 18.2507 |
| 2000's | 100 (44.44) | 29.6817 |
| 2010's | 76 (33.78) | 24.3611 |
| 2020's | 3 (1.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bares, R; Ebinger, M; Handgretinger, R; Schäfer, JF; Storz, C; Tsiflikas, I | 1 |
| Komatsu, J; Nakajima, K; Okuda, K | 1 |
| Agarwala, S; Arora, S; Bal, C; Khadgawat, R; Kumar, R; Passah, A; Tripathi, M | 1 |
| Aldridge, MD; Biassoni, L; Bomanji, JB; Gains, JE; Gaze, MN; Mattoli, MV; Shankar, A | 1 |
| Ali, T; Allan, L; Barker, S; Barnett, N; Ciafone, J; Colloby, SJ; Donaghy, PC; Durcan, R; Firbank, MJ; Hamilton, CA; Howe, K; Lawley, S; Lloyd, J; O'Brien, J; Petrides, GS; Roberts, G; Taylor, JP; Thomas, AJ | 1 |
| Fujita, M; Iida, O; Kanda, T; Mano, T; Masuda, M; Matsuda, Y; Morozumi, T; Sunaga, A; Uematsu, M | 1 |
| Kubota, K; Nakajima, K; Oda, H; Okuda, K; Tsuji, S; Yokoyama, K; Yoneyama, T; Yoshita, M | 1 |
| Hu, Q; Liu, AG; Liu, SY; Wang, YQ; Xia, J; Zhang, A; Zhang, H; Zhang, LQ; Zhang, XL | 1 |
| Curl, K; Hansen, CL | 1 |
| Huo, L; Li, F; Wang, H; Xu, D; Zhu, S; Zhu, W | 1 |
| Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Komatsu, J; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamada, M; Yamasaki, J; Yamashina, S; Yoshita, M | 1 |
| Brandl, SJ; Braune, S | 1 |
| Alves Do Rego, C; Anheim, M; Lagha-Boukbiza, O; Lefebvre, F; Marcel, C; Namer, IJ; Renaud, M; Tranchant, C | 1 |
| Hasegawa, Y; Maki, F; Nakamura, H; Nakashima, Y; Okada, Y; Sasaki, N; Sasaki, O; Shiraishi, M | 1 |
| Berg, D; Postuma, RB | 1 |
| Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E | 1 |
| Asayama, S; Asayama, T; Fujita, K; Ito, H; Kaneko, S; Kusaka, H; Morita, J; Nagashima, M; Nakamura, M; Nakamura, S; Nakano, S; Nishii, M; Oki, M; Saito, A; Tsuge, A; Wate, R | 1 |
| Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN | 1 |
| Charron, M | 1 |
| Bal, C; Dhull, VS; Jeph, S; Kumar, R; Naswa, N; Reddy, RM; Sharma, P; Singh, H | 1 |
| Antonio, R; Lucio, CG; Luigi, M; Oscar, T; Vincenzo, C | 1 |
| Castaldi, P; Giordano, A; Perotti, G; Rufini, V; Treglia, G | 1 |
| Bellersen, L; Bulten, BF; de Geus-Oei, LF; Kapusta, L; Mavinkurve-Groothuis, AM; van der Palen, RL; van Laarhoven, HW | 1 |
| Ammini, AC; Arora, S; Bal, C; Chumber, S; Dhull, VS; Durgapal, P; Gupta, P; Kumar, R; Malhotra, A; Sharma, P | 1 |
| Deeg, KH; Gerdemann, C | 1 |
| Bergestuen, DS; Khan, MS; Kim, MK; Oberg, K; Rinke, A; Salazar, R; Thirlwell, C; Toumpanakis, C | 1 |
| Bongers, V; Hagen, PJ; Somsen, GA; van Eck-Smit, BL; Verberne, HJ; Verschure, DO | 1 |
| Adachi, H; Honda, Y; Hoshizaki, H; Kan, H; Kawaguchi, R; Miyaishi, Y; Oshima, S; Toyama, T; Yamashita, E | 1 |
| da Rocha, ET; de Oliveira, EP; dos Santos, MJ; Miranda, DP; Salemi, VM; Verberne, HJ | 1 |
| Abe, Y; Asano, Y; Iizuka, T; Inoue, Y; Kikuchi, K; Matsunaga, K; Nishiyama, K | 1 |
| Fuchimoto, Y; Fujimura, T; Hoshino, K; Hotta, R; Kuroda, T; Matsufuji, H; Morikawa, Y; Nakahara, T; Shimojima, N | 1 |
| Bax, JJ; Chen, J; Folks, RD; Garcia, EV; Jacobson, AF; Manatunga, DN; Zhou, W; Zhou, Y | 1 |
| Imanishi, Y; Kinuya, S; Matsuo, S; Nakajima, K; Okuda, K; Wakabayashi, H; Yoshimura, M | 1 |
| Fraedrich, G; Frech, A; Gasser, RW; Gastl, G; Gautsch, K; Kroiss, A; Madleitner, R; Nilica, B; Shulkin, BL; Sprinzl, GM; Uprimny, C; Url, C; Virgolini, IJ | 1 |
| De Deyn, PP; Engelborghs, S; Goeman, J; Hauth, L; Martin, JJ; Slaets, S; Van Acker, F; Versijpt, J | 1 |
| Choi, HS; Lee, BC; Lee, WW; Park, HJ; So, Y; Suh, M | 1 |
| Armstrong, IS; Arumugam, P; Asghar, O; Malik, RA; Ray, SG; Schmitt, M | 1 |
| Butler, J; Chen, J; Clements, IP; Folks, RD; Garcia, EV; Jacobson, AF | 1 |
| Arai, H; Arai, T; Asada, T; Fujishiro, H; Hanyu, H; Iizuka, O; Iseki, E; Kashihara, K; Kosaka, K; Maruno, H; Mizukami, K; Mizuno, Y; Mori, E; Nakajima, K; Nakamura, H; Nakano, S; Nakashima, K; Nishio, Y; Orimo, S; Samuraki, M; Takahashi, A; Taki, J; Tokuda, T; Urakami, K; Utsumi, K; Wada, K; Washimi, Y; Yamada, M; Yamasaki, J; Yamashina, S; Yoshita, M | 1 |
| Bevilacqua, A; Cuocolo, A; de Lucia, C; Femminella, GD; Ferrara, N; Ferro, G; Filardi, PP; Formisano, R; Leosco, D; Pagano, G; Paolillo, S; Parisi, V; Pellegrino, T; Prastaro, M; Rengo, G | 1 |
| Bertagna, F; Bertoli, M; Camoni, L; Campini, R; Fracassi, F; Giubbini, R; Marcassa, C; Milan, E; Motta, F; Paghera, B; Rodella, C | 1 |
| Agostini, D; Defer, GL; Lamotte, G; Lebasnier, A; Morello, R | 1 |
| Choi, EK; Chung, YA; Kim, JS; Oh, JK; Song, IU | 1 |
| Agarwala, S; Bakhshi, S; Bal, C; Bhatnagar, V; Dhull, VS; Kumar, R; Kundu, P; Patel, C; Sharma, P | 1 |
| Bartenstein, P; Coppenrath, E; Fendler, WP; Ilhan, H; Pfluger, T; Schmid, I; Thornton, HI; von Schweinitz, D; Wenter, V | 1 |
| Higuchi, T; Javadi, M; Lapa, C; Nekolla, SG; Onthank, D; Rischpler, C; Robinson, S; Samnick, S; Schwaiger, M; Werner, RA | 1 |
| Adam, JA; Bleeker, G; Caron, HN; Hooft, L; Kremer, LC; Tytgat, GA; van Dalen, EC | 1 |
| Aragon, DC; da Rocha, ET; da Silva, ET; Dos Santos, MJ; Junior, JS; Verberne, HJ | 1 |
| Carrió, I; Folks, RD; Garcia, EV; Henzlova, MJ; Jacobson, AF; Jain, D; Travin, MI; van Eck-Smit, BLF; Verberne, HJ | 1 |
| Černý, I; Kašpárková, H; Prášek, J | 1 |
| Carson, RE; Chan, C; Gallezot, JD; Huang, Y; Lampert, RJ; Lin, SF; Liu, C; Liu, YH; Prasad, R; Sinusas, AJ; Stacy, MR; Thorn, SL; Wu, J; Zonouz, TH | 1 |
| Attena, E; Cannavo, A; Cuocolo, A; de Lucia, C; Dellegrottaglie, S; Femminella, GD; Ferrara, N; Filardi, PP; Formisano, R; Komici, K; Leosco, D; Memmi, A; Pagano, G; Paolillo, S; Parisi, V; Pellegrino, T; Petraglia, L; Rengo, G; Trimarco, B; Vitale, DF | 1 |
| Antelmi, L; Biffi, AM; Calcagni, ML; Capitanio, S; Cecchin, D; Corso, A; Gabanelli, SV; Guerra, UP; Merello, M; Micheli, A; Muscio, C; Nobili, F; Piccardo, A; Pinto, P; Riva, R; Sacco, L; Stefanini, S; Tettamanti, M; Tiraboschi, P; Vai, P; Vidale, S; Volterrani, D | 1 |
| Ishimori, T; Nakamoto, R; Nakamoto, Y; Togashi, K | 1 |
| Castellani, R; Drobics, M; Giammarile, F; Ladenstein, R; Lambert, B; Lewington, V; Lynch, T; McEwan, AJB; Poetschger, U; Sever, ZB; Shulkin, B; Staudenherz, A | 1 |
| Furusho, H; Hamaoka, T; Inoue, O; Kaneko, S; Kato, T; Matsuo, S; Mukai, Y; Murai, H; Okabe, Y; Okuyama, Y; Takamura, M; Takashima, SI; Tokuhisa, H; Usui, S | 1 |
| Hashimoto, E; Hatakeyama, S; Ishii, T; Iwamoto, T; Kawanishi, C; Kawasaki, K; Kobayashi, S; Makino, K; Mikuni, K; Murayama, T; Tateno, M; Tsujino, H; Ukai, W; Utsumi, K | 1 |
| Inui, Y; Kosaka, K; Manabe, Y; Toyama, H | 1 |
| Furukawa, Y; Kobayashi, S; Shirasaka, T; Tateno, M; Utumi, K | 1 |
| Amanuma, M; Arisaka, Y; Endo, K; Higuchi, T; Nakajima, T; Oriuchi, N; Takano, A; Taketomi-Takahashi, A; Tsushima, Y | 1 |
| Arita, H; Fujita, S; Futami, S; Kawai, K; Kiyohara, S; Nagamachi, S; Nakazato, M; Nishii, R; Tamura, S; Wakamatsu, H; Yamashita, S | 1 |
| Angeletti, G; Avenia, N; Caracò, C; Chiofalo, MG; Colao, A; Faggiano, A; Ferolla, P; Grimaldi, F; Lombardi, G; Mozzillo, N; Pezzullo, L; Santeusanio, F | 1 |
| Kinuya, S; Kizu, H; Nakajima, K; Noguchi, A; Onoguchi, M; Takayama, T; Tsushima, H | 1 |
| Iida, K; Motiduki, N; Nakaya, Y; Sakata, K | 1 |
| Hosokawa, R; Kawamura, T; Kitagawa, N; Mizuta, E; Nishio, R; Oeda, T; Ohba, M; Sawada, H; Shimohama, S; Takahashi, R; Takeuchi, H; Yamakawa, K; Yamamoto, K | 1 |
| Cheung, NK; Kramer, K; Kushner, BH; Modak, S | 1 |
| Castel, V; Farto, JC; Heiba, S; Jacobson, AF; Kadota, R; Khutoryansky, N; Pfluger, T; Serafini, A; Tulchinsky, M; Tumeh, S; Vik, TA | 1 |
| Chung, EJ; Kim, BJ; Lee, GH; Lee, WY; Yoon, WT | 1 |
| Furman, WL; Gelfand, MJ; Salisbury, S; Sharp, SE; Shulkin, BL | 1 |
| Brouwers, AH; de Jong, JR; de Vries, EG; Dierckx, RA; Elsinga, PH; Fiebrich, HB; Jager, PL; Kema, IP; Kerstens, MN; Links, TP; Pijl, ME; Sluiter, WJ; van der Wal, JE | 1 |
| Ishibashi, K; Ishii, K; Ishiwata, K; Kanemaru, K; Mizusawa, H; Murayama, S; Oda, K; Saito, Y | 1 |
| Heiba, SI; Jacobson, AF; Khutoryansky, N; Mankoff, DA; Neumann, DR; O'Dorisio, MS; Pacak, K; Serafini, AN; Tumeh, SS; Waxman, AD; Wiseman, GA | 1 |
| Buckley, SE; Chittenden, SJ; Flux, GD; Meller, ST; Saran, FH | 1 |
| Carlson, D; Groshen, S; Han, MM; Hawkins, R; Jackson, HA; Mari Aparici, C; Maris, J; Matthay, KK; Quach, A; Taggart, DR; Villablanca, JG; Ye, W | 1 |
| Leite, MA; Nascimento, OJ | 1 |
| Diederich, NJ; Fröhlich, I; Pilloy, W; Vaillant, M | 1 |
| Chan, KW; Cheung, WS; Fung, LM; Kwan, WK; Lee, KF; Lee, KM; Li, JK; Tam, VH; Yau, JS; Yeung, CK; Yeung, VT; Yuen, YP | 1 |
| Hosoya, T; Ishikawa, T; Kinuya, S; Konishi, T; Matsubara, K; Matsuo, S; Nakajima, K; Okuda, K | 1 |
| Decristoforo, C; Gabriel, M; Kendler, D; Kranewitter, C; Kroiss, A; Putzer, D; Santner, W; Uprimny, C; Virgolini, IJ; Waitz, D; Warwitz, B | 1 |
| Mochio, S; Oka, H; Toyoda, C; Yogo, M | 1 |
| Haruta, H; Kishi, M; Ogata, T; Ogawa, E; Sakakibara, R; Tateno, F; Terada, H | 1 |
| Antke, C; Beu, M; Müller, HW; Nikolaus, S; Schnitzler, A; Südmeyer, M; Wojtecki, L; Zizek, T | 1 |
| Kondo, C; Kusakabe, K; Momose, M; Uchiyama, S; Uchiyama, Y | 1 |
| Nakamagoe, K; Takeda, T; Tamaoka, A; Watanabe, M | 1 |
| Baba, T; Hasegawa, T; Kikuchi, A; Konno, M; Sugeno, N; Takeda, A | 1 |
| Currie, GM; Iqbal, B; Jelinek, HF; Kiat, H; Trifunovic, M; Wang, L; Wheat, JM | 1 |
| Izawa, MO; Kajimoto, Y; Kondo, T; Miwa, H | 1 |
| Hara, M; Nakagawa, M; Okada, N; Saikawa, T; Shinohara, T; Takahashi, N; Yoshimatsu, H; Yufu, K | 1 |
| Chen, J; Folks, RD; Garcia, EV; Jacobson, AF; Manatunga, DN; Verdes, L | 1 |
| Inaba, A; Mizusawa, H; Orimo, S; Suzuki, M | 1 |
| Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; King, KS; Ling, A; Pacak, K; Rao, JU; Timmers, HJ; Wesley, RA; Whatley, M | 1 |
| Al-Nahhas, A; Dhillo, W; Goldstone, AP; Martin, NM; Maurice, JB; Meeran, K; Naji, M; Palazzo, F; Ramachandran, R; Tan, T; Todd, JF; Troke, R; Win, Z | 1 |
| Codreanu, I; Servaes, S; Yang, J; Zhuang, H | 1 |
| Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL | 1 |
| Ashino, K; Ebina, T; Inoue, T; Ishigami, T; Ishikawa, Y; Kuji, N; Matsubara, S; Minamisawa, K; Mitani, I; Ochiai, H; Oka, T; Sumita, S; Takahashi, N; Umemura, S | 1 |
| Hoshizaki, H; Kasama, S; Kurabayashi, M; Oshima, S; Suzuki, T; Taniguchi, K; Toyama, T | 1 |
| Kurihara, T; Narita, M | 1 |
| Iida, Y; Kanegawa, N; Kawashima, H; Kinoshita, T; Kiyono, Y; Nishimura, H; Ogawa, M; Saji, H; Tamaki, N | 1 |
| Fukuyama, T; Imamura, Y | 1 |
| Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsushita, K; Ohkusu, Y; Oka, T; Sumita, S; Takahashi, N; Uchino, K; Umemura, S; Yamakawa, Y | 1 |
| Asai, M; Fukunami, M; Hirata, A; Hoki, N; Hori, M; Kioka, H; Kumagai, K; Kusuoka, H; Makino, N; Ogita, H; Shimonagata, T; Yamada, T | 1 |
| Chikamori, T; Hatano, T; Hida, S; Iino, H; Kamada, T; Morishima, T; Usui, Y; Watanabe, K; Yamashina, A; Yanagisawa, H | 1 |
| Bunko, H; Kinuya, S; Li, XF; Michigishi, T; Mori, H; Shiba, K; Shuke, N; Tonami, N; Watanabe, N; Yokoyama, K | 1 |
| Brunot, B; Grunenberger, F; Jaeck, D; Noblet-Dick, M; Schlienger, JL | 1 |
| Asselain, B; Edeline, V; Hartmann, O; Lumbroso, J; Matthay, KK; Michon, J; Tanguy, ML; Valteau-Couanet, D; Zucker, JM | 1 |
| Kanaya, S; Kobayashi, H; Kondo, C; Kusakabe, K; Mitsuhashi, N; Momose, M | 1 |
| Ino, H; Kawano, M; Mabuchi, H; Nakajima, K; Oe, K; Shimizu, M; Taki, J; Terai, H; Uchiyama, K; Yamaguchi, M | 1 |
| Gerson, MC; McGuire, N; Wagoner, LE | 1 |
| Brophy, P; Charron, M; Hickeson, MP; Kang, TI; Khan, J; Maris, JM; Nevrotski, T; Zhuang, H | 1 |
| Abe, K; Hashimoto, T; Koizumi, K; Nishina, T | 1 |
| Yamashina, S; Yamazaki, J | 1 |
| Chin, K; Hosokawa, R; Mishima, M; Nakamura, T; Ohi, M; Sumi, K; Takahashi, K | 1 |
| Camacho, V; Carrió, I; Estorch, M; Flotats, A; Fuertes, J; Kulisewsky, J; Mena, E; Narula, J | 1 |
| Fujimoto, S; Hisatake, S; Inoue, A; Nakano, H; Yamashina, H; Yamashina, S; Yamazaki, J | 1 |
| Ichikawa, S; Ishikawa, T; Kasama, S; Kumakura, H; Kurabayashi, M; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Ishikawa, A; Kurata, C; Uehara, A | 1 |
| Akashi, YJ; Miyake, F; Musha, H; Nakazawa, K; Sakakibara, M; Sasaka, K | 1 |
| An, R; Biersack, HJ; Ezziddin, S; Gao, Z; Logvinski, T | 1 |
| Affleck, DJ; Alston, KL; Vaidyanathan, G; Welsh, P; Zalutsky, MR | 1 |
| Hamada, M; Hara, Y; Hiasa, G; Ogimoto, A; Ohtsuka, T; Saeki, H; Shigematsu, Y | 1 |
| Abe, S; Arao, T; Inoue, S; Kubota, I; Sata, M; Shibata, Y; Takabatake, N; Takeishi, Y | 1 |
| Kyuma, M; Nakata, T; Shimamoto, K; Takahashi, T; Tsuchihashi, K; Wakabayashi, T | 1 |
| Caracò, C; Klain, M; Mainolfi, C; Maurea, S; Salvatore, M | 1 |
| Amano, H; Fujimoto, S; Inoue, A; Ishida, S; Nakano, H; Yamashina, H; Yamashina, S; Yamazaki, J | 1 |
| Hamamoto, M; Katayama, Y; Nagashima, J; Nagayama, H; Ueda, M | 1 |
| Gimelli, A; Giorgetti, A; Kusch, A; L'abbate, A; Marini, C; Marzullo, P; Sambuceti, G; Sereni, N | 1 |
| Choi, SH; Ghim, T; Goo, HW; Moon, HN; Seo, JJ | 1 |
| Bley, TA; Brink, I; Hoegerle, S; Klisch, J | 1 |
| Busemann Sokole, E; de Jong, WM; Feenstra, C; Somsen, GA; van Eck-Smit, BL; Verberne, HJ | 1 |
| Aktas, RG; Altun, A; Durmuş-Altun, G; Salihoglu, YS; Yigitbasi, NO | 1 |
| Hellström, PM; Jacobsson, H; Jonas, E; Larsson, SA | 1 |
| Azuma, A; Ito, K; Kinoshita, N; Matsubara, H; Sugihara, H | 1 |
| Kinouchi, H; Mizoi, K; Naitoh, Y; Sasajima, T; Tomura, N; Watarai, J | 1 |
| Estorch, M | 1 |
| Abe, K; Chikamori, T; Hanyu, H; Hirao, K; Iwamoto, T; Kanetaka, H; Koizumi, K; Shimizu, S; Usui, Y; Yamashina, A | 1 |
| Cohen, M; Siddiqui, A | 1 |
| Ayala, A; Carrasquillo, JA; Chen, CC; Del Corral, P; Ilias, I; Mamede, M; Pacak, K; Whatley, M | 1 |
| Delong, ER; Eubanks, S; Feldman, JM; Guller, U; Oertli, D; Turek, J | 1 |
| Ahmadzadehfar, H; Biersack, HJ; Bucerius, J; Ezziddin, S; Fischer, HP; Logvinski, T; Palmedo, H; Reinhardt, MJ; Yong-Hing, C | 1 |
| Buscombe, JR; Caplin, ME; Gnanasegaran, G; Hilson, AJ; Quigley, AM; Roberts, D; Shah, T | 1 |
| Acil, T; Breithardt, G; Kies, P; Paul, M; Schäfers, K; Schäfers, M; Schober, O; Wichter, T | 1 |
| Chen, WP; Kajinami, K; Matsunari, I; Matsuya, T; Murakami, Y; Nakajima, K; Nekolla, SG; Nomura, Y; Takamatsu, H; Taki, J | 1 |
| Bui, F; Cecchin, D; Lumachi, F; Mantero, F; Marzola, MC; Opocher, G; Scaroni, C; Zucchetta, P | 1 |
| Bui, F; Cecchin, D; Cristina Marzola, M; Grassetto, G; Lumachi, F; Tregnaghi, A; Zucchetta, P | 1 |
| Matsumoto, Y; Nakajima, K; Noguchi-Shinohara, M; Taki, J; Yamada, M; Yokoyama, K; Yoshita, M | 1 |
| Anan, F; Eshima, N; Masaki, T; Nakagawa, M; Saikawa, T; Takahashi, N; Yonemochi, H; Yoshimatsu, H | 1 |
| Ceriani, L; Ghelfo, A; Giovanella, L; Squin, N | 1 |
| Cobbe, SM; Martin, W; Motherwell, DW; Petrie, MC | 1 |
| Carvalho, PA; da Fonseca, BL; de Almeida, AS; Gutfilen, B; Lima, SL; Mansur, J; Pessoa, PM; Xavier, SS | 1 |
| Al-Nahhas, A; Gishen, P; Lewington, V; Rubello, D; Todd, JF; Towey, D; Win, Z | 1 |
| Endo, K; Hasegawa, A; Hatori, T; Kasama, S; Kurabayashi, M; Nakano, A; Suguta, M; Toyama, T | 1 |
| Boesch, S; Donnemilier, E; Heute, D; Köllensperger, M; Liener, C; Mair, KJ; Mueller, J; Poewe, W; Sawires, M; Scherfler, C; Schocke, MF; Seppi, K; Virgolini, I; Wenning, GK | 1 |
| Barsaoui, S; Ben Brahim, H; Gharssallah, L; Hammami, H; Hassine, L; Mhiri, A; Oubich, F; Sellem, A | 1 |
| Inui, Y; Iwata, N; Katada, K; Kosaka, K; Manabe, Y; Sarai, M; Sato, T; Toyama, H | 1 |
| Agostini, D; Habraken, JB; Jacobson, AF; van Eck-Smit, BL; Verberne, HJ | 1 |
| Kasanuki, H; Kobayashi, H; Kusakabe, K; Momose, M; Nagamatsu, H | 1 |
| Agostini, D; Banerjee, G; Burchert, W; Estorch, M; Jacobson, AF; Knuuti, J; Povinec, P; Sambuceti, G; Unlu, M; Verberne, HJ | 1 |
| Cichocki, A; Cwikla, JB; Durlik, M; Jeziorski, KG; Malkowski, B; Nasierowska-Guttmejer, A; Seklecka, N; Stepień, K; Walecki, J; Zgliczynski, W | 1 |
| Hashimoto, A; Kyuma, M; Nagahara, D; Nakata, T; Noda, R; Shimamoto, K; Shimoshige, S; Tsuchihashi, K; Uno, K; Wakabayashi, T | 1 |
| Abd El-Aal, H | 1 |
| Ichikawa, S; Kasama, S; Kumakura, H; Kurabayashi, M; Matsumoto, N; Nakazawa, M; Sato, Y; Sumino, H; Suzuki, T; Takayama, Y; Toyama, T | 1 |
| Beck, D; Delaloye, AB; Hadj-Djilani, NL; Laurini, R; Lebtahi, NE | 1 |
| Bellini, F; Ianni, L; Lanzillotti, R; Mannelli, M; Pupilli, C | 1 |
| Crasset, V; Dekoninck, W; Delcourt, E | 1 |
| Ando, S; Egashira, K; Fukai, T; Koyanagi, S; Kuroiwa, M; Kuwabara, Y; Sasaki, M; Takeshita, A; Tsutsui, H | 1 |
| Ishikawa, H; Kawakami, Y; Nakamura, Y; Okuda, Y; Sone, H; Yamaoka, T; Yamashita, K | 1 |
| Advani, SH; Kurkure, PA; Murugesan, S; Noronha, OP; Samuel, AM; Sonawane, GA | 1 |
| Elgazzar, AH; Gelfand, MJ; Golsch, GJ; Kriss, VM; Masters, PR | 1 |
| Bathmann, J; Moser, E; Neumann, HP; Sigmund, G | 1 |
| Clesham, CJ; Dollery, CT; Kennedy, A; Lavender, JP; Wilkins, MR | 1 |
| Hara, M; Kinoshita, R; Kojima, A; Ooyama, Y; Shimomura, O; Takahashi, M; Tomiguchi, S; Tsuji, A | 1 |
| Hariya, A; Hayashi, I; Kobayashi, T; Makuuchi, H; Maruno, H; Murata, H; Naruse, Y; Yamamoto, T | 1 |
| Acar, P; Aggoun, Y; Bonnet, D; Iserin, L; Kachaner, J; Merlet, P; Sidi, D | 1 |
| Buxton-Thomas, M; Ramage, JK; Williams, R | 1 |
| Hashimoto, A; Iimura, O; Nagao, K; Nakata, T; Tanaka, S; Tsuchihashi, K | 1 |
| Fisher, GA; Rufini, V; Shapiro, B; Shulkin, BL; Sisson, JC | 1 |
| Carnaille, B; Huglo, D; Marchandise, X; Nocaudie-Calzada, M; Proye, C | 1 |
| Nielsen, BV; Nielsen, JT; Rehling, M | 1 |
| Beierwaltes, W; Froelich, J; Gonin, J; Macfarlane, D; Mangner, T; Shapiro, B; Wieland, D | 1 |
| Gross, MD; Shapiro, B; Shulkin, BL; Sisson, JC; Zempel, S | 1 |
| Han, R; Mitrovic, S; Zagar, I | 1 |
| Bertolazzi, L; Cabria, M; Claudiani, F; Conte, M; De Bernardi, B; Garaventa, A; Lanino, E; Scopinaro, G; Stimamiglio, P; Villavecchia, GP | 1 |
| De Sio, L; Deb, G; Di Giuda, D; Donfrancesco, A; Giordano, A; Petrone, A; Rufini, V; Troncone, L | 1 |
| Kuroda, T; Mizutani, S; Nakano, M; Saeki, M | 1 |
| Cuocolo, A; Maurea, S; Neumann, RD; Reynolds, JC; Salvatore, M | 1 |
| Adachi, I; Hirota, Y; Ito, T; Kawamura, K; Moriguchi, A; Narabayashi, I; Otake, Y; Suwa, M | 1 |
| Andrich, MP; Majd, M; Movassaghi, N; Shalaby-Rana, E | 1 |
| Chauvot, P; Giammarile, F | 1 |
| Kurata, C; Sakata, K; Shirotani, M; Yoshida, H | 1 |
| de Kraker, J; Ghazzar, N; Hartmann, O; Hattner, R; Hoefnagel, CA; Jamadar, DA; Kim, E; Kloos, R; Leung, A; Lizotte, P; Lumbroso, J; Rufini, V; Shapiro, B; Shulkin, BL; Sisson, JC; Thein, A; Troncone, L | 1 |
| Farahati, J; Reiners, C | 1 |
| Kopf, D; Lehnert, H; Mundschenk, J; Schulz, C | 1 |
| Bauduceau, B; Cosson, E; Ducorps, M; Foehrenbach, H; Gaillard, JF; Mayaudon, H; Pellan, M; Prevost, G | 1 |
| Fabre, M; Gauthier, F; Gruner, M; Hartmann, O; Helardot, PG; Josset, P; Larroquet, M; Lumbroso, J; Martelli, H; Michon, J; Paraf, F; Patte, C; Ricard, M; Tabone, MD; Terrier-Lacombe, MJ; Wioland, M | 1 |
| Kobayashi, H | 1 |
| Bomanji, JB; Costa, DC | 1 |
| Furuta, N; Hasegawa, N; Kiyota, H; Ohishi, Y; Yoshigoe, F | 1 |
| Francis, IR; Shapiro, B; Shulkin, BL; Sisson, JC; Thompson, NW | 1 |
| Beijnen, JH; Sparidans, RW; Taal, BG | 1 |
| Fujii, T; Hanaoka, M; Kobayashi, T; Koizumi, T; Kubo, K; Yamaguchi, S; Yamamoto, H | 1 |
| Tsuji, Y; Yokoyama, H | 1 |
| Hara, Y; Hayashi, A; Horiike, S; Ishii, K; Kubo, A; Kusakabe, K; Masaki, H; Murata, H | 1 |
| Emoto, Y; Fujii, H; Fujino, N; Fujita, S; Ino, H; Mabuchi, H; Nakajima, K; Okeie, K; Shimizu, M; Taki, J; Yamaguchi, M; Yasuda, T | 1 |
| De Graaf, JS; Dullaart, RP; Kok, T; Piers, DA; Zwierstra, RP | 1 |
| Chou, S; Yanchar, NL | 1 |
| Chatal, JF; Kraeber-Bodéré, F; Le Bodic, MF; Resche, I; Rousseau, C | 1 |
| Antloga, CM; Bromberg-Marin, G; Maciel, BC; Marin-Neto, JA; Pazin-Filho, A; Pintya, AO; Sarabanda, AV; Simões, MV | 1 |
| Berglund, AS; Hulthén, UL; Manhem, P; Thorsson, O; Törnquist, C; Wollmer, P | 1 |
| Klain, M; Mainolfi, C; Maurea, S; Salvatore, M; Ziviello, M | 1 |
| Lawson, MA | 1 |
| d'Herbomez, M; Gouze, V; Huglo, D; Marchandise, X; Nocaudie, M; Pattou, F; Proye, C; Wémeau, JL | 1 |
| Doppman, JL; Eisenhofer, G; Goldstein, DS; Pacak, K; Shulkin, BL; Udelsman, R | 1 |
| Hirao, K; Iwado, Y; Kohno, M; Kondo, I; Matsuo, H; Mizushige, K; Nozaki, S; Senda, S | 1 |
| Garaventa, A | 1 |
| Boersma, HH; De Brauw, LM; Kho, TL; Liem, IH; Van Kroonenburgh, MJ; Wensing, JW | 1 |
| Futami, S; Jinnouchi, S; Kawai, K; Kurose, T; Matsukura, S; Nagamachi, S; Nishii, R; Tamura, S | 1 |
| de Milliano, PA; Lie, KI; Tijssen, JG; van Eck-Smit, BL | 1 |
| Hirano, Y; Ikawa, H; Ishikawa, K; Nakagawa, K; Ozasa, Y; Uehara, H; Yamada, S; Yamamoto, T | 1 |
| Kikkawa, M; Kubota, T; Nakamura, T; Nishimura, T; Okuyama, C; Ushijima, Y | 1 |
| Dykes, TM; Greene, MK; Hattner, RS; Moraldo, TV; Parisi, MT; Sandler, ED | 1 |
| Arndt, JW; Falke, TH; Hoogma, RP; Sandler, MP; van der Mey, AG; van Erkel, AR; van Gils, AP | 1 |
| de Graaf, JS; de Lange, WE; Klooster, NJ; Piers, DA; Zwierstra, RP | 1 |
| Brunetti, A; Caracò, C; Cuocolo, A; Klain, M; Lastoria, S; Lembo, G; Maurea, S; Maurelli, L; Salvatore, M | 1 |
| Beam, CA; Coleman, RE; Feldman, JM; Hanson, MW; Leight, GS | 1 |
| Vaughan, KD | 1 |
17 review(s) available for 3-iodobenzylguanidine and Sensitivity and Specificity
| Article | Year |
|---|---|
Comparison of diagnosing and staging accuracy of PET (CT) and MIBG on patients with neuroblastoma: Systemic review and meta-analysis.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2017 |
Prodromal Parkinson's Disease: The Decade Past, the Decade to Come.
Topics: 3-Iodobenzylguanidine; Anxiety; Biomarkers; Biopsy; Brain; Cognitive Dysfunction; Depression; Erectile Dysfunction; Female; Functional Neuroimaging; Humans; Hypotension, Orthostatic; Male; Neuroimaging; Olfaction Disorders; Parkinson Disease; Prodromal Symptoms; Radionuclide Imaging; Radiopharmaceuticals; REM Sleep Behavior Disorder; Risk Assessment; Sensitivity and Specificity; Sleepiness; Substantia Nigra; Urination Disorders | 2019 |
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon | 2013 |
Contemporary approach to diagnosis and treatment of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Bone and Bones; Central Nervous System Neoplasms; Child; Child, Preschool; Clinical Trials as Topic; Diagnostic Imaging; Disease Models, Animal; Female; Humans; Infant; Kinetics; Male; Medical Oncology; Mice; Neuroblastoma; Octreotide; Patient Safety; Radiometry; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Remission Induction; Sensitivity and Specificity; Tissue Distribution | 2013 |
Neurological applications for myocardial MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Heart; Humans; Myocardial Perfusion Imaging; Parkinson Disease; Sensitivity and Specificity; Sympathetic Nervous System | 2013 |
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Paraganglioma; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Combination of cross-sectional and molecular imaging studies in the localization of gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Digestive System Neoplasms; Fluorodeoxyglucose F18; Humans; Intestinal Neoplasms; Magnetic Resonance Imaging; Molecular Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Positron-Emission Tomography; Radionuclide Imaging; Receptors, Somatostatin; Sensitivity and Specificity; Stomach Neoplasms; Surveys and Questionnaires; Tomography, X-Ray Computed; Ultrasonography | 2014 |
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Neuroblastoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2015 |
Risk stratification in heart failure using ¹²³I-MIBG.
Topics: 3-Iodobenzylguanidine; Aged; Defibrillators, Implantable; Heart Failure; Humans; Male; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Survival Rate; Tomography, Emission-Computed, Single-Photon | 2011 |
123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis.
Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Neurodegenerative Diseases; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity | 2012 |
Imaging of pheochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2005 |
[Diagnostic problems in pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Algorithms; Biomarkers; Catecholamines; Clonidine; Diagnostic Imaging; Glucagon; Humans; Iodine Radioisotopes; Iodobenzenes; Pheochromocytoma; Sensitivity and Specificity; Vanilmandelic Acid | 1995 |
The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Heart; Hormone Antagonists; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Radiology, Interventional; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Sympathetic Nervous System; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1995 |
[Nuclear medicine diagnosis of pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Recurrence, Local; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity | 1997 |
[Clinical and endocrine diagnosis of pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Clonidine; Humans; Iodine Radioisotopes; Iodobenzenes; Pheochromocytoma; Sensitivity and Specificity; Syndrome | 1997 |
[Myocardial perfusion imagings in acute coronary syndromes].
Topics: 3-Iodobenzylguanidine; Acute Disease; Coronary Disease; Diagnosis, Differential; Fatty Acids; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk; Sensitivity and Specificity; Syndrome; Tomography, Emission-Computed, Single-Photon | 1998 |
Nuclear medicine applications for neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Female; Humans; Male; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pheochromocytoma; Prognosis; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
48 trial(s) available for 3-iodobenzylguanidine and Sensitivity and Specificity
| Article | Year |
|---|---|
Cardiac iodine-123-metaiodobenzylguanidine scintigraphy may be useful to identify pathologic from physiologic sinus bradycardia.
Topics: 3-Iodobenzylguanidine; Aged; Bradycardia; Cardiac Imaging Techniques; Clinical Decision-Making; Electrocardiography; Female; Humans; Male; Pacemaker, Artificial; Preoperative Care; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Combination of ¹²³I-metaiodobenzylguanidine scintigraphy and flow-mediated dilation for the detection of patients with coronary spastic angina.
Topics: 3-Iodobenzylguanidine; Acetylcholine; Aged; Angina Pectoris; Coronary Stenosis; Coronary Vasospasm; Diagnosis, Computer-Assisted; Female; Humans; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2014 |
An improved method for estimating the heart-to-mediastinum ratio from cardiac sympathetic nerve imaging with low-energy high-resolution collimators.
Topics: 3-Iodobenzylguanidine; Algorithms; Equipment Design; Equipment Failure Analysis; Female; Heart; Heart Failure; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Mediastinum; Myocardium; Radiation Dosage; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System | 2014 |
1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Heart Failure; Humans; Male; Metabolic Clearance Rate; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Gland; Tomography, Emission-Computed, Single-Photon | 2016 |
(123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Male; Middle Aged; Neuroblastoma; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed, Single-Photon; Young Adult | 2009 |
MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
Topics: 3-Iodobenzylguanidine; Adenosine; Aged; Autonomic Nervous System Diseases; Diagnosis, Differential; Female; Galvanic Skin Response; Heart; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Parkinsonian Disorders; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Respiration; Sensitivity and Specificity; Sympathetic Fibers, Postganglionic; Tomography, Emission-Computed, Single-Photon; Valsalva Maneuver | 2009 |
Whole-body dosimetry for individualized treatment planning of 131I-MIBG radionuclide therapy for neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Body Burden; Child; Child, Preschool; Female; Humans; Infant; Male; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Whole-Body Counting; Young Adult | 2009 |
Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Diagnostic accuracy of combined FP-CIT, IBZM, and MIBG scintigraphy in the differential diagnosis of degenerative parkinsonism: a multidimensional statistical approach.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Benzamides; Diagnosis, Differential; Humans; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Pyrrolidines; Radionuclide Imaging; ROC Curve; Sensitivity and Specificity; Tropanes | 2011 |
Quantitative I-123 mIBG SPECT in differentiating abnormal and normal mIBG myocardial uptake.
Topics: 3-Iodobenzylguanidine; Aged; Algorithms; Diagnosis, Differential; Female; Heart; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Myocardium; Pilot Projects; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2012 |
Clinical implications of cardiac (123)I-meta-iodobenzylguanidine scintigraphy and cardiac natriuretic peptides in patients with heart disease.
Topics: 3-Iodobenzylguanidine; Angina Pectoris; Atrial Natriuretic Factor; Cardiomyopathies; Chronic Disease; Female; Follow-Up Studies; Heart Diseases; Heart Valve Diseases; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2002 |
Scintigraphic assessment of patients with electrocardiographic left ventricular hypertrophy with ST-T changes without apparent cause.
Topics: 3-Iodobenzylguanidine; Biopsy; Coronary Angiography; Electrocardiography; Exercise Test; Fatty Acids; Female; Follow-Up Studies; Heart; Humans; Hypertrophy, Left Ventricular; Iodobenzenes; Male; Middle Aged; Myocardium; Radionuclide Ventriculography; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2002 |
Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy--importance of background correction for quantification of MIBG activity.
Topics: 3-Iodobenzylguanidine; Artifacts; Cardiomyopathy, Dilated; Female; Follow-Up Studies; Humans; Image Enhancement; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Regression Analysis; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Ventricular Dysfunction, Left | 2002 |
Anti-tachycardia therapy can improve altered cardiac adrenergic function in tachycardia-induced cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Anti-Arrhythmia Agents; Cardiomyopathies; Cardiomyopathy, Dilated; Diagnosis, Differential; Echocardiography; Female; Humans; Male; Mediastinum; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Stroke Volume; Systole; Tachycardia; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Ventricular Function, Left | 2003 |
High-tension electrical injury to the heart as assessed by radionuclide imaging.
Topics: 3-Iodobenzylguanidine; Adult; Echocardiography; Electric Injuries; Electrocardiography; Heart; Heart Injuries; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium | 2002 |
Scatter correction by two-window method standardizes cardiac I-123 MIBG uptake in various gamma camera systems.
Topics: 3-Iodobenzylguanidine; Artifacts; Calibration; Equipment Failure; Female; Gamma Cameras; Heart; Heart Diseases; Humans; Image Enhancement; Male; Middle Aged; Myocardium; Phantoms, Imaging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity | 2003 |
Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Cardiomyopathy, Hypertrophic; Female; Heart Ventricles; Humans; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2003 |
Sympathetic nervous system function as measured by I-123 metaiodobenzylguanidine predicts transplant-free survival in heart failure patients with idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Sympathetic Nervous System | 2003 |
Clinical usefulness of iodine-123-MIBG scintigraphy for patients with neuroblastoma detected by a mass screening survey.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Female; Homovanillic Acid; Humans; Infant; Japan; Male; Mass Screening; Neuroblastoma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Vanilmandelic Acid; Whole-Body Counting | 2003 |
Challenging the neuronal MIBG uptake by pharmacological intervention: effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake.
Topics: 3-Iodobenzylguanidine; Administration, Oral; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Artifacts; Female; Heart; Heart Conduction System; Humans; Male; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2004 |
Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy for predicting the effectiveness of beta-blockers in patients with dilated cardiomyopathy from the standpoint of long-term prognosis.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Cardiomyopathy, Dilated; Disease-Free Survival; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ultrasonography | 2004 |
Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Topics: 3-Iodobenzylguanidine; Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dopamine; Drug Combinations; Female; Furosemide; Heart; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Improvement of cardiac sympathetic innervation by renal transplantation.
Topics: 3-Iodobenzylguanidine; Adult; Arrhythmias, Cardiac; Autonomic Nervous System Diseases; Child; Female; Heart Rate; Humans; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2004 |
123I-MIBG myocardial scintigraphy in patients with "takotsubo" cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Female; Humans; Male; Myocardial Stunning; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Syndrome; Ventricular Dysfunction, Left | 2004 |
The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; Middle Aged; Octreotide; Patient Selection; Pentetic Acid; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2004 |
Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Disease Progression; Endothelial Cells; Female; Humans; Lung; Male; Pulmonary Fibrosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Vascular Diseases | 2005 |
Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Comorbidity; Drug Combinations; Female; Heart Failure; Humans; Japan; Male; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in the prediction of cardiac events in patients with cardiomyopathy showing stabilization of symptoms or preserved cardiac function.
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Cardiomyopathies; Causality; Comorbidity; Female; Heart Failure; Humans; Incidence; Japan; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sex Distribution; Survival Analysis; Tomography, Emission-Computed, Single-Photon | 2004 |
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Longitudinal Studies; Male; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
Extension of myocardial necrosis differently affects MIBG retention in heart failure caused by ischaemic heart disease or by dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Autonomic Nervous System Diseases; Cardiomyopathy, Dilated; Coronary Artery Disease; Heart; Heart Failure; Humans; Male; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2005 |
Assessment of Takotsubo cardiomyopathy (transient left ventricular apical ballooning) using 99mTc-tetrofosmin, 123I-BMIPP, 123I-MIBG and 99mTc-PYP myocardial SPECT.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Cardiomyopathies; Diagnosis, Differential; Fatty Acids; Female; Humans; Iodobenzenes; Male; Middle Aged; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Syndrome; Technetium Tc 99m Pyrophosphate; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Cardiomyopathies; Critical Care; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Sympathetic Nervous System; Ventricular Fibrillation | 2006 |
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas: a prospective study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2006 |
Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Confounding Factors, Epidemiologic; Diagnosis, Differential; Female; Humans; Japan; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Prevalence; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
Topics: 3-Iodobenzylguanidine; Death, Sudden, Cardiac; Defibrillators, Implantable; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Selection; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Iodine-123-MIBG SPECT versus planar imaging in children with neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neural Crest; Neuroblastoma; Pheochromocytoma; Sensitivity and Specificity; Sympatholytics; Tomography, Emission-Computed, Single-Photon | 1994 |
[The clinical value of MIBG myocardial spect before and after CABG--comparison with TI myocardial spect].
Topics: 3-Iodobenzylguanidine; Coronary Artery Bypass; Coronary Disease; Denervation; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Radionuclide Imaging; Sensitivity and Specificity; Sympathetic Nervous System; Thallium Radioisotopes | 1995 |
Intraoperative localization of neuroblastoma in children with 123I- or 125I-radiolabeled metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Child, Preschool; Female; Fibrosis; Gamma Cameras; Humans; Infant; Iodine Radioisotopes; Lymphatic Metastasis; Male; Monitoring, Intraoperative; Necrosis; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 1998 |
Diagnosis of pheochromocytoma using [123I]-compared with [131I]-metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity | 1999 |
[Noninvasive screening for pheochromocytoma in patients with an incidentally discovered adrenal mass: usefulness of provocative test with metoclopramide and 131I-metaiodobenzylguanidine scintigraphy].
Topics: 3-Iodobenzylguanidine; Adenoma; Adrenal Gland Neoplasms; Adult; Biomarkers; Catecholamines; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Metoclopramide; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 1999 |
[Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Carcinoma, Medullary; Child; Child, Preschool; Female; Humans; Infant; Iodine Radioisotopes; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Thyroid Neoplasms | 2000 |
Cardiac sympathetic activity in the asymmetrically hypertrophied septum in patients with hypertension or hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Analysis of Variance; Blood Pressure Determination; Cardiomyopathy, Hypertrophic; Female; Heart Rate; Heart Septum; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Probability; Radiopharmaceuticals; Regression Analysis; Sensitivity and Specificity; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2000 |
Relation of regional sympathetic denervation and myocardial perfusion disturbance to wall motion impairment in Chagas' cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Analysis of Variance; Chagas Cardiomyopathy; Female; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Probability; Radionuclide Imaging; Reference Values; Regional Blood Flow; Sensitivity and Specificity; Statistics, Nonparametric; Sympathectomy; Sympathetic Nervous System; Thallium Radioisotopes; Ventricular Dysfunction, Left | 2000 |
Serial change in 123I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Blood Glucose; Diabetes Mellitus, Type 2; Electrocardiography; Evaluation Studies as Topic; Female; Follow-Up Studies; Fructosamine; Heart; Humans; Male; Middle Aged; Myocardium; Neural Conduction; Radionuclide Ventriculography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sex Factors; Tibial Nerve; Time Factors; Treatment Outcome | 2002 |
Cardiac 123 I-MIBG imaging and clinical variables in risk stratification in patients with heart failure treated with beta blockers.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Aged; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Male; Metoprolol; Norepinephrine; Oxygen Consumption; Predictive Value of Tests; Prospective Studies; Radionuclide Ventriculography; Radiopharmaceuticals; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume | 2002 |
Utility of follow-up studies using meta-[123 I]iodobenzylguanidine scintigraphy for detecting recurrent neuroblastoma.
Topics: 3-Iodobenzylguanidine; Biomarkers, Tumor; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2002 |
160 other study(ies) available for 3-iodobenzylguanidine and Sensitivity and Specificity
| Article | Year |
|---|---|
Diagnostic value of whole-body MRI in Opsoclonus-myoclonus syndrome: a clinical case series (3 case reports).
Topics: 3-Iodobenzylguanidine; Adrenalectomy; Female; Ganglioneuroblastoma; Humans; Infant; Magnetic Resonance Imaging; Male; Opsoclonus-Myoclonus Syndrome; Radionuclide Imaging; Sensitivity and Specificity; Whole Body Imaging | 2019 |
What does diagnostic threshold mean? Deterministic and probabilistic considerations.
Topics: 3-Iodobenzylguanidine; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Humans; Iodine Radioisotopes; Lewy Body Disease; Middle Aged; Probability; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
Prospective evaluation of 68Ga-DOTANOC positron emission tomography/computed tomography and 131I-meta-iodobenzylguanidine single-photon emission computed tomography/computed tomography in extra-adrenal paragangliomas, including uncommon primary sites and
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Aged; Child; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Positron Emission Tomography Computed Tomography; Prospective Studies; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Young Adult | 2019 |
68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy.
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Sensitivity and Specificity; Whole Body Imaging | 2020 |
Accuracy of Cardiac Innervation Scintigraphy for Mild Cognitive Impairment With Lewy Bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2021 |
Cross calibration of
Topics: 3-Iodobenzylguanidine; Aged; Calibration; Female; Gamma Cameras; Heart; Humans; Image Interpretation, Computer-Assisted; Male; Mediastinum; Myocardium; Phantoms, Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2017 |
Topics: 3-Iodobenzylguanidine; Iodine Radioisotopes; Mediastinum; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2019 |
Validation of Iodine-131-meta-iodobenzylguanidine cardiac scintigraphy in Parkinsonism: A preliminary study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Cross-Sectional Studies; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Sensitivity and Specificity | 2018 |
Sensitivity and specificity of cardiac metaiodobenzylguanidine scintigraphy in the early diagnosis of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Early Diagnosis; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity | 2019 |
Prospective study of relevance of
Topics: 3-Iodobenzylguanidine; Biomarkers; Clonidine; Diagnosis, Differential; Female; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2018 |
Usefulness of the combination of iodine-123-metaiodobenzylguanidine scintigraphy and iodine-123-ioflupane scintigraphy in new-onset Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Female; Humans; Logistic Models; Male; Middle Aged; Nortropanes; Parkinson Disease; Radionuclide Imaging; Sensitivity and Specificity | 2018 |
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult | 2019 |
Levodopa challenge test and (123) I-metaiodobenzylguanidine scintigraphy for diagnosing Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antiparkinson Agents; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2013 |
Can hybrid SPECT-CT overcome the limitations associated with poor imaging properties of 131I-MIBG?: Comparison with planar scintigraphy and SPECT in pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Female; Humans; Male; Multimodal Imaging; Observer Variation; Pheochromocytoma; Predictive Value of Tests; Radionuclide Imaging; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2013 |
Catecholamines influence myocardial 123I MIBG uptake in neuroblastoma patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Catecholamines; Child; Child, Preschool; Female; Heart; Humans; Male; Myocardium; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Diagnostic accuracy of (68)Ga-DOTANOC PET/CT imaging in pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Humans; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Sonographic diagnosis of pheochromocytoma in childhood and adolescence.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Child; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Male; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity; Ultrasonography | 2013 |
Impact of a predefined mediastinal ROI on inter-observer variability of planar ¹²³I-MIBG heart-to-mediastinum ratio.
Topics: 3-Iodobenzylguanidine; Aged; Female; Heart; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Mediastinum; Myocardium; Observer Variation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
Differential effects of variation in athletes training on myocardial morphophysiological adaptation in men: focus on ¹²³I-MIBG assessed myocardial sympathetic activity.
Topics: 3-Iodobenzylguanidine; Adult; Blood Pressure; Heart Rate; Heart Ventricles; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Resistance Training; Sensitivity and Specificity; Sports; Stroke Volume; Sympathetic Nervous System; Ventricular Function, Left; Young Adult | 2014 |
Application of nuclear medicine to achieve less invasive surgery for malignant solid tumors in children.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Child; Child, Preschool; Feasibility Studies; Female; Humans; Male; Neuroblastoma; Radiopharmaceuticals; Radiosurgery; Retrospective Studies; Rhabdomyosarcoma; Sensitivity and Specificity; Sentinel Lymph Node Biopsy | 2014 |
I-123 mIBG and Tc-99m myocardial SPECT imaging to predict inducibility of ventricular arrhythmia on electrophysiology testing: a retrospective analysis.
Topics: 3-Iodobenzylguanidine; Aged; Electrophysiologic Techniques, Cardiac; Female; Humans; Male; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tachycardia, Ventricular; Tomography, Emission-Computed, Single-Photon; Ventricular Fibrillation | 2014 |
Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations.
Topics: 3-Iodobenzylguanidine; Artifacts; Calibration; Equipment Design; Equipment Failure Analysis; Gamma Cameras; Heart; Humans; Japan; Mediastinum; Myocardium; Phantoms, Imaging; Quality Assurance, Health Care; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2014 |
(68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Multimodal Imaging; Octreotide; Organometallic Compounds; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Reference Standards; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2015 |
Case report of PET/CT imaging of a patient with neuroblastoma using 18F-FPBG.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Biopsy; Bone Marrow; Bone Neoplasms; Guanidines; Humans; Male; Multimodal Imaging; Neoplasms, Multiple Primary; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tibia; Tomography, X-Ray Computed | 2014 |
Individuals with impaired glucose tolerance demonstrate normal cardiac sympathetic innervation using I-123 mIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Heart; History, Ancient; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Young Adult | 2015 |
Quantitative iodine-123-metaiodobenzylguanidine (MIBG) SPECT imaging in heart failure with left ventricular systolic dysfunction: Development and validation of automated procedures in conjunction with technetium-99m tetrofosmin myocardial perfusion SPECT.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Female; Heart Failure; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Machine Learning; Male; Middle Aged; Multimodal Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Pattern Recognition, Automated; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2016 |
Diagnostic accuracy of 123I-meta-iodobenzylguanidine myocardial scintigraphy in dementia with Lewy bodies: a multicenter study.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Lewy Bodies; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2015 |
Alterations of left ventricular deformation and cardiac sympathetic derangement in patients with systolic heart failure: a 3D speckle tracking echocardiography and cardiac ¹²³I-MIBG study.
Topics: 3-Iodobenzylguanidine; Autonomic Nervous System Diseases; Echocardiography, Three-Dimensional; Female; Heart Failure; Humans; Male; Middle Aged; Multimodal Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2015 |
Accuracy and cutoff values of delayed heart to mediastinum ratio with (123)I-metaiodobenzylguanidine cardiac scintigraphy for Lewy body disease diagnoses.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Female; Heart; Humans; Lewy Body Disease; Male; Mediastinum; Middle Aged; Parkinson Disease; Parkinsonian Disorders; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2015 |
Comparison of I-123 MIBG planar imaging and SPECT for the detection of decreased heart uptake in Parkinson disease.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Heart; Humans; Male; Middle Aged; Parkinson Disease; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2015 |
Diagnostic value of 18F-FDG PET/CT in paediatric neuroblastoma: comparison with 131I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Combined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High Accuracy.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adolescent; Adult; Biomarkers, Tumor; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Neuroblastoma; Prognosis; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2015 |
Retention Kinetics of the 18F-Labeled Sympathetic Nerve PET Tracer LMI1195: Comparison with 11C-Hydroxyephedrine and 123I-MIBG.
Topics: 3-Iodobenzylguanidine; Animals; Autonomic Nervous System Diseases; Ephedrine; Fluorine Radioisotopes; Fluorobenzenes; Guanidines; Isotope Labeling; Kinetics; Metabolic Clearance Rate; Organ Specificity; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Assessment of late anthracycline-induced cardiotoxicity by
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Anthracyclines; Antineoplastic Agents; Autonomic Nervous System Diseases; Brazil; Cardiotoxicity; Causality; Child; Child, Preschool; Comorbidity; Female; Humans; Male; Neoplasms; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2017 |
Assessment of
Topics: 3-Iodobenzylguanidine; Arrhythmias, Cardiac; Causality; Comorbidity; Female; Heart Failure; Humans; Incidence; Internationality; Male; Middle Aged; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Survival Rate | 2017 |
Superiority of SPECT/CT over planar 123I-mIBG images in neuroblastoma patients with impact on Curie and SIOPEN score values.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Female; Humans; Image Enhancement; Infant; Infant, Newborn; Male; Neoplasm Staging; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography | 2016 |
Quantitative Analysis of Dynamic 123I-mIBG SPECT Imaging Data in Healthy Humans with a Population-Based Metabolite Correction Method.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Algorithms; Artifacts; Computer Simulation; Female; Heart; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Models, Cardiovascular; Models, Statistical; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2016 |
Impact of aging on cardiac sympathetic innervation measured by
Topics: 3-Iodobenzylguanidine; Aged; Aging; Cardiac Imaging Techniques; Female; Heart Failure; Humans; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 2016 |
(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography and (123) I-metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Corpus Striatum; Diagnosis, Differential; Female; Frontotemporal Dementia; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tropanes | 2016 |
Clinical Significance of Quantitative 123I-MIBG SPECT/CT Analysis of Pheochromocytoma and Paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Aged, 80 and over; Ear Neoplasms; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Paraganglioma; Phantoms, Imaging; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retroperitoneal Neoplasms; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Single Photon Emission Computed Tomography Computed Tomography; Tomography, Emission-Computed, Single-Photon; Urinary Bladder Neoplasms; Young Adult | 2016 |
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Europe; Humans; Image Interpretation, Computer-Assisted; Internationality; Neuroblastoma; Observer Variation; Practice Guidelines as Topic; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2017 |
Significant correlation between renal
Topics: 3-Iodobenzylguanidine; Adult; Female; Humans; Hypertension; Kidney; Male; Muscle, Skeletal; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System | 2017 |
The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Cerebrovascular Circulation; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Lewy Body Disease; Male; Myocardial Perfusion Imaging; Perfusion Imaging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2017 |
123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Alzheimer Disease; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Myocardial Perfusion Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
[Improved diagnosis of dementia with Lewy bodies by the combination of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy and 99mTc-ethylcysteinate dimmer (ECD) brain perfusion SPECT].
Topics: 3-Iodobenzylguanidine; Brain; Cerebrovascular Circulation; Cysteine; Female; Heart; Humans; Iodine Radioisotopes; Lewy Body Disease; Male; Organotechnetium Compounds; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2008 |
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Usefulness of rCBF analysis in diagnosing Parkinson's disease: supplemental role with MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Cerebrovascular Circulation; Cross-Sectional Studies; Diagnosis, Differential; Female; Heart; Humans; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Parkinson Disease; Parkinson Disease, Secondary; Radiopharmaceuticals; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon | 2008 |
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Female; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Postoperative Complications; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms | 2009 |
Localization of metastases from malignant pheochromocytoma in patients undergoing 131I-MIBG therapy with manually fused 123I-MIBG SPECT and CT images.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Feasibility Studies; Pheochromocytoma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2008 |
Frequency and characteristics of extremely low accumulation of 123I-metaiodobenzylguanidine (MIBG) in patients with and without cardiovascular diseases.
Topics: 3-Iodobenzylguanidine; Aging; Cardiovascular Diseases; Female; Heart; Humans; Male; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2008 |
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease.
Topics: 3-Iodobenzylguanidine; Cross-Sectional Studies; Humans; Myocardial Perfusion Imaging; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sensitivity and Specificity | 2009 |
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Bone and Bones; Bone Marrow; Catecholamines; Disease-Free Survival; Female; Humans; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Survival Analysis; Tomography, X-Ray Computed | 2009 |
123I-MIBG scintigraphy and 18F-FDG PET in neuroblastoma.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Fluorodeoxyglucose F18; Humans; Male; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2009 |
6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine exces
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Biomarkers; Catecholamines; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Humans; Hyperplasia; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2009 |
Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET.
Topics: 3-Iodobenzylguanidine; Aged; Brain; Dopamine Antagonists; Female; Heart; Humans; Image Enhancement; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2010 |
Usefulness of 123I-MIBG scintigraphy in the evaluation of patients with known or suspected primary or metastatic pheochromocytoma or paraganglioma: results from a prospective multicenter trial.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Aged; Aged, 80 and over; Europe; Female; Humans; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Young Adult | 2009 |
Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Clinical Trials, Phase I as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Neoplasm Recurrence, Local; Neuroblastoma; Outcome Assessment, Health Care; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease.
Topics: 3-Iodobenzylguanidine; Diabetes Complications; Diabetes Mellitus; Glucose; Humans; Myocardial Perfusion Imaging; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Time Factors | 2010 |
Myocardial MIBG scintigraphy: a useful clinical tool? : A retrospective study in 50 parkinsonian patients.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Aging; Antihypertensive Agents; Diagnosis, Differential; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Parkinsonian Disorders; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Sex Characteristics | 2010 |
Phaeochromocytoma in the Hong Kong Chinese population.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Female; Follow-Up Studies; Hong Kong; Humans; Male; Phenoxybenzamine; Pheochromocytoma; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, X-Ray Computed; Young Adult | 2010 |
Semi-automated algorithm for calculating heart-to-mediastinum ratio in cardiac Iodine-123 MIBG imaging.
Topics: 3-Iodobenzylguanidine; Algorithms; Female; Heart Diseases; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Mediastinum; Middle Aged; Myocardium; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2011 |
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron-Emission Tomography; Reference Standards; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult | 2011 |
Sensitivity and specificity of metaiodobenzylguanidine (MIBG) myocardial accumulation in the diagnosis of Lewy body diseases in a movement disorder clinic.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Female; Humans; Lewy Body Disease; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2011 |
Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Mediastinum; Myocardium; Parkinsonian Disorders; Radionuclide Imaging; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2011 |
Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Area Under Curve; Female; Heart; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardium; Parkinson Disease; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Sympathetic Nervous System | 2011 |
Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
Topics: 3-Iodobenzylguanidine; Aged; Diagnosis, Differential; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity | 2011 |
Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Olfaction Disorders; Parkinson Disease; Radiopharmaceuticals; Sensitivity and Specificity; Ultrasonography, Doppler, Transcranial | 2012 |
Cardiac iodine-123 metaiodobenzylguanidine (123I-MIBG) scintigraphy parameter predicts cardiac and cerebrovascular events in type 2 diabetic patients without structural heart disease.
Topics: 3-Iodobenzylguanidine; Aged; Diabetes Mellitus, Type 2; Female; Follow-Up Studies; Heart Failure; Humans; Iodine Radioisotopes; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Proportional Hazards Models; Radionuclide Imaging; Sensitivity and Specificity; Stroke | 2012 |
Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
A comparison of the performance of ⁶⁸Ga-DOTATATE PET/CT and ¹²³I-MIBG SPECT in the diagnosis and follow-up of phaeochromocytoma and paraganglioma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Follow-Up Studies; Humans; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Young Adult | 2012 |
I-131 MIBG post-therapy scan is more sensitive than I-123 MIBG pretherapy scan in the evaluation of metastatic neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Male; Neoplasm Metastasis; Neuroblastoma; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Time Factors; Whole Body Imaging; Young Adult | 2012 |
Characterization of neuroblastic tumors using 18F-FDOPA PET.
Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid | 2013 |
Dobutamine gated blood pool scintigraphy predicts the improvement of cardiac sympathetic nerve activity, cardiac function, and symptoms after treatment in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Case-Control Studies; Digitalis Glycosides; Diuretics; Dobutamine; Echocardiography; Female; Gated Blood-Pool Imaging; Heart; Humans; Iodine Radioisotopes; Male; Metoprolol; Middle Aged; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed, Single-Photon | 2002 |
Age-related changes of myocardial norepinephrine transporter density in rats: implications for differential cardiac accumulation of MIBG in aging.
Topics: 3-Iodobenzylguanidine; Aging; Animals; Autoradiography; Heart; Male; Myocardium; Norepinephrine Plasma Membrane Transport Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Symporters; Tissue Distribution; Whole-Body Counting | 2002 |
Local delivery of (131)I-MIBG to treat peritoneal neuroblastoma.
Topics: 3-Iodobenzylguanidine; Animals; Body Burden; Dose-Response Relationship, Radiation; Female; Injections, Intraperitoneal; Injections, Intravenous; Mice; Mice, Inbred BALB C; Mice, Nude; Neuroblastoma; Organ Specificity; Peritoneal Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Survival Rate; Tissue Distribution; Treatment Outcome; Whole-Body Counting | 2003 |
[Pheochromocytoma in internal medicine: distinctive features and place of 123I MIBG scintigraphy].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Catecholamines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2003 |
Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Disease-Free Survival; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neuroblastoma; Patient Care Planning; Peripheral Blood Stem Cell Transplantation; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Treatment Outcome | 2003 |
Biodistribution of post-therapeutic versus diagnostic (131)I-MIBG scans in children with neuroblastoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Child; Child, Preschool; Chronology as Topic; Female; Humans; Infant; Iodine Radioisotopes; Male; Neoplasm Metastasis; Neuroblastoma; Radiation Dosage; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Tissue Distribution | 2004 |
Role of MIBG myocardial scintigraphy in the assessment of heart failure: the need to establish evidence.
Topics: 3-Iodobenzylguanidine; Clinical Trials as Topic; Evidence-Based Medicine; Heart Failure; Humans; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index | 2004 |
Corrected QT dispersion and cardiac sympathetic function in patients with obstructive sleep apnea-hypopnea syndrome.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Cardiovascular Diseases; Cohort Studies; Electrocardiography; Female; Humans; Male; Middle Aged; Polysomnography; Positive-Pressure Respiration; Probability; Radionuclide Imaging; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sleep Apnea Syndromes; Statistics, Nonparametric | 2004 |
Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.
Topics: 3-Iodobenzylguanidine; Cell Line, Tumor; Humans; Iodobenzenes; Metabolic Clearance Rate; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2004 |
Cardiac sympathetic nerve activity can detect congestive heart failure sensitively in patients with hypertrophic cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiac Volume; Cardiomyopathies; Early Diagnosis; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Sympathetic Nervous System; Ventricular Dysfunction, Left | 2004 |
Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Infant; Iodine Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Muscle, Skeletal; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2005 |
Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study.
Topics: 3-Iodobenzylguanidine; Equipment Failure Analysis; Heart; Image Enhancement; Mediastinum; Myocardium; Organ Specificity; Phantoms, Imaging; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity; Tissue Distribution | 2005 |
Use of iodine-123 metaiodobenzylguanidine scintigraphy for the detection of amiodarone induced pulmonary toxicity in a rabbit model: a comparative study with technetium-99m diethyltriaminepenta acetic acid radioaerosol scintigraphy.
Topics: 3-Iodobenzylguanidine; Aerosols; Amiodarone; Animals; Anti-Arrhythmia Agents; Injections, Intravenous; Lung; Lung Diseases; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Pentetate | 2005 |
Different concentrations of various radiopharmaceuticals in the two main liver lobes: a preliminary study in clinical patients.
Topics: 3-Iodobenzylguanidine; Adult; Age Factors; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Liver Diseases; Male; Middle Aged; Probability; Radiopharmaceuticals; Reference Values; Retrospective Studies; Sensitivity and Specificity; Sex Factors; Time Factors; Tissue Distribution; Tomography, Emission-Computed, Single-Photon | 2005 |
123I-metaiodobenzylguanidine single-photon emission computerized tomography in brain tumors - a preliminary study.
Topics: 3-Iodobenzylguanidine; Adult; Aged, 80 and over; Animals; Brain Neoplasms; Child; Child, Preschool; Diagnosis, Differential; Female; Glioma; Humans; Infant; Magnetic Resonance Imaging; Male; Meningioma; Middle Aged; Neoplasms, Germ Cell and Embryonal; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
From the heart to the brain via cardiac MIBG imaging.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Clinical Trials as Topic; Diagnosis, Differential; Heart; Humans; Lewy Body Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Humans; Iofetamine; Lewy Body Disease; Perfusion; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2006 |
Importance of recognizing differences between bone marrow and bone cortex.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Infant; Iodine Radioisotopes; Lymphoma; Magnetic Resonance Imaging; Male; Muscle Neoplasms; Muscle, Skeletal; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Rhabdomyosarcoma; Sensitivity and Specificity; Tomography, X-Ray Computed; Whole Body Imaging | 2006 |
Discordant localization of 2-[18F]-fluoro-2-deoxy-D-glucose in 6-[18F]-fluorodopamine- and [(123)I]-metaiodobenzylguanidine-negative metastatic pheochromocytoma sites.
Topics: 3-Iodobenzylguanidine; Adult; Dopamine; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2006 |
Detecting pheochromocytoma: defining the most sensitive test.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Child; Female; Humans; Male; Middle Aged; Norepinephrine; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Digestive System Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Neuroendocrine Tumors; Pancreatic Neoplasms; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Sensitivity and Specificity; Somatostatin | 2006 |
Intertumoural variability in functional imaging within patients suffering from neuroendocrine tumours. An observational, cross-sectional study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Neuroendocrine Tumors; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity; Somatostatin; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 2005 |
Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake.
Topics: 3-Iodobenzylguanidine; Animals; Ephedrine; Heart; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Myocardium; Positron-Emission Tomography; Rabbits; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Sympathetic Nervous System; Tissue Distribution | 2006 |
A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2006 |
Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.
Topics: 3-Iodobenzylguanidine; Biomarkers; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic | 2007 |
Chromogranin A immunoradiometric assay in diagnosis of pheochromocytoma: comparison with plasma metanephrines and 123I-MIBG scan.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Biomarkers, Tumor; Chromogranin A; Female; Humans; Immunoradiometric Assay; Male; Metanephrine; Middle Aged; Neoplasm Proteins; Pheochromocytoma; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2006 |
123I- Metaiodobenzylguanidine in chronic heart failure: Is there a clinical use?
Topics: 3-Iodobenzylguanidine; Chronic Disease; Heart Failure; Humans; Metabolic Clearance Rate; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2006 |
Assessment of takotsubo (ampulla) cardiomyopathy using iodine-123 metaiodobenzylguanidine scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Cardiomyopathies; Citrates; Coronary Angiography; Echocardiography; Female; Gallium; Humans; Middle Aged; Myocardial Stunning; Radiopharmaceuticals; Sensitivity and Specificity; Syndrome; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
68Ga-DOTATATE PET in neuroectodermal tumours: first experience.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Female; Humans; Image Enhancement; Male; Middle Aged; Organometallic Compounds; Pheochromocytoma; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2007 |
123I-MIBG imaging can be used to evaluate microvascular disturbance caused by embolization by microdebris after rotational atherectomy.
Topics: 3-Iodobenzylguanidine; Aged; Atherectomy, Coronary; Coronary Artery Disease; Embolism; Female; Humans; Male; Microcirculation; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
Topics: 3-Iodobenzylguanidine; Aged; Analysis of Variance; Area Under Curve; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Heart; Humans; Middle Aged; Multiple System Atrophy; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tilt-Table Test; Time Factors | 2007 |
[Metaiodobenzylguanidine scintigraphy in the diagnosis and followup of neuroblastoma. Apropos of 16 cases].
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Antineoplastic Agents; Bone Marrow Neoplasms; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity | 2007 |
Evaluation of probable or possible dementia with lewy bodies using 123I-IMP brain perfusion SPECT, 123I-MIBG, and 99mTc-MIBI myocardial SPECT.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Brain; Female; Heart; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Perfusion; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2007 |
Variations in 123I-metaiodobenzylguanidine (MIBG) late heart mediastinal ratios in chronic heart failure: a need for standardisation and validation.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Chronic Disease; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Mediastinum; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reference Standards; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Prognostic value of 123I-metaiodobenzylguanidine in patients with various heart diseases.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Female; Follow-Up Studies; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Radiopharmaceuticals; Risk Factors; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2007 |
I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Europe; Heart; Heart Failure; Humans; Middle Aged; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Risk Assessment; Risk Factors; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2008 |
Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Diagnostic Imaging; Female; Humans; Indium Radioisotopes; Intestinal Neoplasms; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Somatostatin; Stomach Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2007 |
Role of radio-iodinated meta-iodo benzyl guanidine in assessment of children with neuroblastoma at NEMROCK.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Biopsy, Needle; Bone and Bones; Bone Marrow; Child; Child, Preschool; Egypt; Female; Heart; Humans; Infant; Iodine Radioisotopes; Male; Mediastinal Neoplasms; Myocardium; Neoplasm Staging; Neuroblastoma; Retrospective Studies; Sensitivity and Specificity | 2006 |
Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
Topics: 3-Iodobenzylguanidine; Aged; Chronic Disease; Comorbidity; Female; Heart Failure; Humans; Incidence; Japan; Male; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Stroke Volume; Survival Analysis; Survival Rate; Ventricular Dysfunction, Left | 2008 |
Diagnosis and follow-up of neuroblastoma by means of iodine-123 metaiodobenzylguanidine scintigraphy and bone scan, and the influence of histology.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child, Preschool; Diphosphonates; False Negative Reactions; False Positive Reactions; Female; Follow-Up Studies; Ganglioneuroblastoma; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Organotechnetium Compounds; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Time Factors | 1995 |
Detection of a carcinoid tumor by the radionuclide method.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Octreotide; Peritoneal Neoplasms; Radionuclide Imaging; Sensitivity and Specificity | 1994 |
Detection of angina-provoking coronary stenosis by resting iodine 123 metaiodobenzylguanidine scintigraphy in patients with unstable angina pectoris.
Topics: 3-Iodobenzylguanidine; Aged; Angina, Unstable; Cardiac Catheterization; Coronary Angiography; Coronary Disease; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Sensitivity and Specificity; Thallium Radioisotopes; Time Factors; Tomography, Emission-Computed, Single-Photon | 1995 |
Pitfalls in scanning for phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenocortical Adenoma; Adult; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Mass Screening; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity | 1994 |
131I-MIBG scintigraphy in neural crest tumours.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Bone Neoplasms; Carcinoma, Medullary; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Neural Crest; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Thyroid Neoplasms | 1994 |
False-positive diagnosis of a pheochromocytoma with I-123 metaiodobenzylguanidine.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; False Positive Reactions; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Kidney Pelvis; Magnetic Resonance Imaging; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity | 1994 |
Meta-iodobenzylguanidine (MIBG) scanning in the diagnosis of phaeochromocytoma.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Catecholamines; Contrast Media; Female; Humans; Iodobenzenes; Male; Middle Aged; Pentolinium Tartrate; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity; Vanilmandelic Acid | 1993 |
[Diagnosis of pheochromocytoma using 131I-MIBG scintigraphy].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Glands; Adult; Aged; Female; Humans; Hypertension; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity | 1993 |
[Cardiac MIBG imaging: a new marker for myocardial function in children?].
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Cardiomyopathies; Child; Child, Preschool; Decision Making; Female; Heart; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Male; Norepinephrine; Prognosis; Radionuclide Imaging; Sensitivity and Specificity; Sympathetic Nervous System; Sympatholytics | 1996 |
Imaging secondary neuroendocrine tumours of the liver: comparison of I123 metaiodobenzylguanidine (MIBG) and In111-labelled octreotide (Octreoscan).
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Neuroendocrine Tumors; Octreotide; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1996 |
Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine tomography in stable coronary artery disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Contrast Media; Coronary Disease; Coronary Vessels; Exercise Test; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Sensitivity and Specificity; Sympathetic Nervous System; Thallium Radioisotopes; Tomography, Emission-Computed | 1996 |
Iodine-123-MIBG imaging of neuroblastoma: utility of SPECT and delayed imaging.
Topics: 3-Iodobenzylguanidine; Child, Preschool; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Retrospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon | 1996 |
Comparison of somatostatin analogue and metaiodobenzylguanidine scintigraphy for the detection of carcinoid tumours.
Topics: 3-Iodobenzylguanidine; Carcinoid Tumor; Contrast Media; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Octreotide; Pentetic Acid; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity | 1996 |
Location of adrenal medullary pheochromocytoma by I-123 metaiodobenzylguanidine SPECT.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenal Medulla; Adult; Aged; Aged, 80 and over; Catecholamines; Child; Humans; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Pheochromocytoma; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ultrasonography | 1996 |
Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
Topics: 3-Iodobenzylguanidine; Adult; Animals; Carcinoid Tumor; Dogs; Enzyme Inhibitors; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Mast-Cell Sarcoma; Mice; Middle Aged; Neoplasms, Experimental; Phenylalanine; Predictive Value of Tests; Radionuclide Imaging; Rats; Sensitivity and Specificity; Serotonin; Somatostatin; Tissue Distribution; Tryptophan Hydroxylase | 1996 |
Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Carcinoid Tumor; Carcinoma, Medullary; Child; False Negative Reactions; False Positive Reactions; Follow-Up Studies; Heart; Humans; Hyperaldosteronism; Injections, Intravenous; Insulinoma; Iodine Radioisotopes; Iodobenzenes; Middle Aged; Myocardium; Neuroblastoma; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Salivary Glands; Sensitivity and Specificity; Thyroid Neoplasms | 1995 |
Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Biopsy; Bone Marrow Neoplasms; Bone Neoplasms; Child; Child, Preschool; Diagnostic Imaging; False Negative Reactions; Female; Follow-Up Studies; Forecasting; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neoplasm Staging; Neuroblastoma; Pelvic Bones; Radionuclide Imaging; Radiopharmaceuticals; Remission Induction; Sensitivity and Specificity; Spinal Neoplasms; Thoracic Neoplasms | 1995 |
[123I]MIBG scintigraphy in neuroblastoma: a comparison between planar and SPECT imaging.
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; Diagnostic Imaging; Female; Follow-Up Studies; Humans; Image Enhancement; Infant; Infant, Newborn; Injections, Intravenous; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm, Residual; Neuroblastoma; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1995 |
Clinical application of minimal residual neuroblastoma cell detection by reverse transcriptase-polymerase chain reaction.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow; Bone Marrow Transplantation; Child; False Negative Reactions; Gene Expression Regulation, Neoplastic; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasm Staging; Neoplasm, Residual; Neoplastic Cells, Circulating; Neuroblastoma; Polymerase Chain Reaction; Prognosis; Risk Factors; RNA-Directed DNA Polymerase; RNA, Messenger; Sensitivity and Specificity; Tyrosine 3-Monooxygenase; Vanilmandelic Acid | 1997 |
Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Contrast Media; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Male; Paraganglioma; Pheochromocytoma; Sensitivity and Specificity; Tomography, X-Ray Computed | 1996 |
Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Bisoprolol; Cardiomyopathy, Dilated; Echocardiography; Female; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Logistic Models; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Sensitivity and Specificity; Treatment Outcome | 1997 |
In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Cause of Death; Child, Preschool; Disease-Free Survival; Female; Follow-Up Studies; Ganglioneuroblastoma; Gene Amplification; Genes, myc; Humans; Indium Radioisotopes; Infant; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Somatostatin; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 1997 |
The place of mIBG imaging in the neuroblastoma diagnostic strategy.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Contrast Media; Diagnosis, Differential; Fractures, Stress; Humans; Iodine Radioisotopes; Iodobenzenes; Magnetic Resonance Imaging; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Tibial Fractures | 1997 |
Iodine-123 metaiodobenzylguanidine cardiac imaging to identify and localize vasospastic angina without significant coronary artery narrowing.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Angina Pectoris, Variant; Contrast Media; Coronary Vasospasm; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity | 1997 |
Specificity of radioiodinated MIBG for neural crest tumors in childhood.
Topics: 3-Iodobenzylguanidine; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Iodine Radioisotopes; Iodobenzenes; Male; Neuroblastoma; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity | 1997 |
[Value of scintigraphy using meta-iodo-benzyl-guanidine (MIBG) in the investigation of cardiac autonomic neuropathy in diabetic patients. Comparison with Ewing tests].
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Blood Pressure; Diabetic Neuropathies; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 1997 |
Crisis after angiography: time for MIBG.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Humans; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 1998 |
Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
Bioanalysis of m-iodobenzylguanidine in plasma by high-performance liquid chromatography after derivatization with benzoin.
Topics: 3-Iodobenzylguanidine; Aged; Benzoin; Chromatography, High Pressure Liquid; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 1999 |
Serial scintigraphic assessment of iodine-123 metaiodobenzylguanidine lung uptake in a patient with high-altitude pulmonary edema.
Topics: 3-Iodobenzylguanidine; Altitude Sickness; Endothelium, Vascular; Energy Metabolism; Humans; Iodine Radioisotopes; Lung; Male; Middle Aged; Pulmonary Edema; Radionuclide Imaging; Sensitivity and Specificity | 1999 |
Limited role of meta-iodobenzylguanidine scintigraphy in imaging phaeochromocytoma in patients with multiple endocrine neoplasia type II.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Adult; Algorithms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2000 |
Pitfalls in the interpretation of MIBG scans in cervical neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bias; Biopsy; Head and Neck Neoplasms; Horner Syndrome; Humans; Infant; Male; Neoplasm Staging; Neuroblastoma; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, X-Ray Computed | 2001 |
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting adrenal masses.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Role of molecular imaging in management of nonhypersecreting adrenal masses.
Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Fluorodeoxyglucose F18; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Biomarkers, Tumor; Chromogranin A; Chromogranins; Female; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Prospective Studies; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
A "pheo" lurks: novel approaches for locating occult pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenalectomy; Carrier Proteins; Dopamine; Epinephrine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Normetanephrine; Pheochromocytoma; Radiopharmaceuticals; Sensitivity and Specificity; Symporters; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vena Cava, Inferior | 2001 |
Ultrasonic tissue characterization can predict beta-blocker efficacy in dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Antagonists; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Case-Control Studies; Dobutamine; Echocardiography, Doppler; Female; Heart; Humans; Iodine Radioisotopes; Male; Middle Aged; Propanolamines; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2001 |
Does a "false-negative" MIBG scan predict a better outcome in neuroblastoma patients?
Topics: 3-Iodobenzylguanidine; Child; Child, Preschool; False Negative Reactions; Female; Humans; Male; Neuroblastoma; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2001 |
Compensatory uptake of I-123 MIBG in the contralateral adrenal gland after removal of a pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Female; Humans; Hyperplasia; Iodine Radioisotopes; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2002 |
Diagnosis of vasospastic angina by hyperventilation and cold-pressor stress echocardiography: comparison to I-MIBG myocardial scintigraphy.
Topics: 3-Iodobenzylguanidine; Acetylcholine; Adult; Aged; Angina Pectoris, Variant; Cold Temperature; Coronary Angiography; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Radionuclide Imaging; Sensitivity and Specificity | 2002 |
Efficacy of metaiodobenzylguanidine as a scintigraphic agent for the detection of neuroblastoma.
Topics: 3-Iodobenzylguanidine; Bone and Bones; Bone Neoplasms; Contrast Media; Humans; Iodine Radioisotopes; Iodobenzenes; Neuroblastoma; Radionuclide Imaging; Sensitivity and Specificity; Technetium Tc 99m Medronate | 1992 |
MR imaging and MIBG scintigraphy of pheochromocytomas and extraadrenal functioning paragangliomas.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Contrast Media; Diagnosis, Differential; Female; Humans; Iodobenzenes; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Endocrine Neoplasia; Paraganglioma, Extra-Adrenal; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 1991 |
[Comparison of iodine scintigraphy and computerized tomography in the localization of pheochromocytoma].
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; False Negative Reactions; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity; Sympatholytics; Tomography, X-Ray Computed | 1991 |
[131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adrenal Glands; Adult; Aged; Catecholamines; Contrast Media; Evaluation Studies as Topic; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity; Tomography, X-Ray Computed | 1991 |
Iodine 131-labeled metaiodobenzylguanidine scintigraphy and biochemical analyses in suspected pheochromocytoma.
Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Norepinephrine; Pheochromocytoma; Radionuclide Imaging; Sensitivity and Specificity; Vanilmandelic Acid | 1991 |
Sipple syndrome.
Topics: 3-Iodobenzylguanidine; Humans; Iodine Radioisotopes; Iodobenzenes; Multiple Endocrine Neoplasia; Radiography; Sensitivity and Specificity | 1989 |